These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2200108)

  • 21. Clinical trials of immunosuppression and immunomodulation in multiple sclerosis.
    Kappos L
    J Neuroimmunol; 1988 Dec; 20(2-3):261-8. PubMed ID: 3058744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triple immunosuppressive therapy in immunologic high-risk renal allograft recipients.
    Cole E; Robinson C; Bear R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2026-7. PubMed ID: 2652662
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparative clinical trial of cyclosporine in multiple sclerosis: the pros.
    Dommasch D
    Neurology; 1988 Jul; 38(7 Suppl 2):28-9. PubMed ID: 3290711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bacterial infection complications in the early period after kidney transplantation: azathioprine vs cyclosporin A].
    Janda P; Prát V
    Cas Lek Cesk; 1987 Dec; 126(52):1617-9. PubMed ID: 3327588
    [No Abstract]   [Full Text] [Related]  

  • 25. Elective conversion from cyclosporin to azathioprine in living related donor kidney transplants.
    Sobh MA; Eldein AB; Moustafa FE; Ghoneim MA
    Nephrol Dial Transplant; 1987; 2(4):258-60. PubMed ID: 3118269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunosuppressive treatment of multiple sclerosis. 3. Results of treatment with azathioprine and antilymphocytic globulin (author's transl)].
    Frick E; Angstwurm H; Strauss G
    MMW Munch Med Wochenschr; 1974 Nov; 116(48):2105-12. PubMed ID: 4216823
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of renal transplantation rejection. Cyclosporin A versus conventional treatment with azathioprine, prednisone and antithymocyte immunoglobulin in primary cadaveric renal transplantation.
    Hall BM; Tiller DJ; Horvath JS; Duggin GG; Johnson JR; Roy LP; Hurley B; Harris JP; Rogers JR; Stephen MS
    Med J Aust; 1985 Feb; 142(3):179-85. PubMed ID: 3881654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combined immunosuppression (cyclosporin, azathioprine, methylprednisolone) in patients at immunological risk after kidney transplantation].
    Hillebrand G; Castro LA; Illner WD; Schleibner S; Land W; Gurland HJ
    Z Urol Nephrol; 1985 Dec; 78(12):667-71. PubMed ID: 3913221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer incidence in renal transplant patients treated with azathioprine or cyclosporine.
    Sheil AG; Flavel S; Disney AP; Mathew TH; Hall BM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2214-6. PubMed ID: 3274496
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical trials of multiple sclerosis therapies: improvements to demonstrate long-term patient benefit.
    Carroll WM
    Mult Scler; 2009 Aug; 15(8):951-8. PubMed ID: 19465446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is long-term therapy without cyclosporin A (CsA) indispensable or dangerous? One-year results of a prospective randomized trial.
    Büsing M; Hölzer H; Schareck WD; Mellert J; Greger B; Hopt UT; Lauchart W
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1601-3. PubMed ID: 2652521
    [No Abstract]   [Full Text] [Related]  

  • 32. [Are there any changes in CSF IgG levels in multiple sclerosis treated for long periods with an immunosuppressive agent (azathioprine)?].
    Oger J; Cloarec L; Chatel M; Sabouraud O
    Nouv Presse Med; 1973 Feb; 2(7):443. PubMed ID: 4631717
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunosuppressive treatment im multiple sclerosis].
    Mertin J
    Fortschr Med; 1980 Oct; 98(37):1431-6. PubMed ID: 6253370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased frequency of posttransplant lymphomas in patients treated with cyclosporin, azathioprine, and prednisone.
    Smith JL; Wilkinson AH; Hunsicker LG; Tobacman J; Kapelanski DP; Johnson M; Wright FH; Behrendt DM; Corry RJ
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3199-200. PubMed ID: 2650451
    [No Abstract]   [Full Text] [Related]  

  • 35. Randomised double blind controlled trial of cyclosporin in multiple sclerosis.
    Rudge P; Koetsier JC; Mertin J; Mispelblom Beyer JO; Van Walbeek HK; Clifford Jones R; Harrison J; Robinson K; Mellein B; Poole T
    J Neurol Neurosurg Psychiatry; 1989 May; 52(5):559-65. PubMed ID: 2659736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A long-term double-blind controlled study on the effect of azathioprine in the treatment of multiple sclerosis.
    Minderhoud JM; Prange AJ; Luyckx GJ
    Clin Neurol Neurosurg; 1988; 90(1):25-8. PubMed ID: 3359729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No shortcuts to outcome in MS clinical trials?
    Koch-Henriksen N
    Neurology; 2009 Feb; 72(8):686-7. PubMed ID: 19237696
    [No Abstract]   [Full Text] [Related]  

  • 38. [Current therapy of multiple sclerosis: value of cyclosporin A and FK 506].
    Hohlfeld R
    Nervenarzt; 1991 Feb; 62(2):136-8. PubMed ID: 1709725
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cyclosporin A in cadaveric kidney transplantation. A randomized study].
    Griñó JM; Seron D; Castelao AM; Sabaté I; Gil-Vernet S; Andrés E; Sabater R; Franco E; Torras J; Alsina J
    Med Clin (Barc); 1988 May; 90(18):719-23. PubMed ID: 3050303
    [No Abstract]   [Full Text] [Related]  

  • 40. [Results of cyclosporin treatment of severe, chronic psoriasis vulgaris].
    Engst R; Huber J
    Hautarzt; 1989 Aug; 40(8):486-9. PubMed ID: 2676910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.